title: Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation.
authors: James T
authors: JT
authors: Lane
authors: David E
authors: DE
authors: Odegaard
authors: Claire E
authors: CE
authors: Haire
authors: Dean S
authors: DS
authors: Collier
authors: Lucile E
authors: LE
authors: Wrenshall
authors: R Brian
authors: RB
authors: Stevens
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D005260:Female; D005919:Glomerular Filtration Rate; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use*; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D006442:Glycated Hemoglobin; D011719:Pyrazines; D000068900:Sitagliptin Phosphate; D014230:Triazoles; C517652:hemoglobin A1c protein, human